Angiogenic proceed is abundant in lung cancer and the LL‐2 cells with high expression levels of bFGF and VEGFA were selected to investigate the tumor inhibition of Peptibody vaccine in vivo [27]. The gene discussed is FGF2; the disease is lung carcinoma.